However, Eli Lilly, the maker of Zepbound, received FDA approval on April 1, 2026 for Foundayo (orforglipron), a once-daily oral GLP-1 weight loss pill that can be taken any time of day, with or without food
Sign up for THE SPILL now.
The GLP-1 class of drugs isn't recommended if you have a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia, or a history of pancreatitis
Gut evaluation and repair: address dysbiosis, leaky gut, and digestive support
The coordinate increase of the two enzymes in the glutathione oxidation/reduction cycle indicates that there was increased usage and recycling of glutathione in susceptible plants even though the total amount of glutathione remained stable
Medications and Supplements to Consider and Avoid 3